Inositol hexaphosphate (IP6)

The brand Tad is taking

Inositol hexaphosphate (IP6) has shown impressive anti-tumor effects in scientific studies in the USA, Japan, and elsewhere (see websites mentioned below for details). Through a complex process I couldn’t explain if my life depended on it, it can target malignant cells and revert them to normal cell function.

We first heard about IP6 from Ed Bauman — one more thing to thank him for. Not surprisingly, our oncologist never mentioned it. Despite very promising studies, it’s not one of the annointed chemotherapy drugs from Big Pharma, so it is relegated to the sidelines.

IP6 derived from rice bran is available in pill form. IP-6 occurs naturally in grains like brown rice and corn, sesame seeds, legumes, and other high-fiber foods. It is a food, not a drug — meaning no digestion issues and no detox issues when used in recommended doses. Since it could help a lot and couldn’t hurt, it has become a regular part of Tad’s regimen.

Any trained scientists among you will understand the research better than I do, so I invite you to see the following. As for me, just reading the abstracts was encouraging enough to put it on our list.

Here are a few interesting tidbits from the research:

“Nature’s most effective iron-chelating molecule is inositol hexaphosphate (IP6), found naturally in seeds and bran. IP6 is a selective agent against cancer cells. Because cancer cells are high in iron content, IP6 directs most of its attention to abnormal cells. IP6 selectively removes iron from tumors cells, which deprives them of their primary growth factor. IP6 does not remove iron from red blood cells, which are tightly bound to hemoglobin. Unlike cancer drugs, healthy cells are not affected with IP6, so IP6 has very low toxicity. [Deliliers GL, British J Haematology 117: 577–87, 2002]”

“There have been numerous lab dish and animal studies that conclusively prove IP6 is an effective and non-toxic anti-cancer molecule. But the National Cancer Institute has never seen fit to conduct a human trial even though IP6 made it on a list of promising anti-cancer agents. [Fox CH, Complementary Therapy Med 10: 229–34, 2003]”

“In 2001 Food and Drug Administration researchers reported that 8 of 12 chelating agents tested were mutagenic (caused gene mutations). Among the four non-toxic chelators was IP6. [Whittaker P, Environmental and Molecular Mutagenesis 38: 347–56, 2001]”

As an alternative to chelating drugs, IP6 has been shown to desirably alter the expression of proteins produced by the p21 and p53 genes that control cancer growth, but goes unused as a cancer treatment. [Saied IT, Anticancer Research 18: 1479–84, 1998]”

IP6 enhances the anti-cancer effects of Adriamycin and Tamoxifen, two commonly used cancer drugs. [Tantivejkul K, Breast Cancer Research Treatment 79: 301–12, 2003]”


Speak Your Mind